Skip to Main Content


Skip Nav Destination
Issue Cover
Current Issue
Volume 1,
Issue 1,
March 2024

Featured Content

KIR3DL1-HLA-Bw status in CML is associated with achievement of TFR: the POKSTIC trial, a multicenter observational study

Real-world comparison of daratumumab-based regimens in relapsed/refractory multiple myeloma using health record data

Comparison of TP53 mutations in myelodysplasia and acute leukemia suggests divergent roles in initiation and progression

Close Modal

or Create an Account

Close Modal
Close Modal